Search Results

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.

• Authors : Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester, UK. .; Lee M

Subjects: Chemoradiotherapy*/Chemoradiotherapy*/Chemoradiotherapy*/methods ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/therapy ; Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/Uterine Cervical Neoplasms*/drug therapy

• Source: BMC cancer [BMC Cancer] 2024 Jun 07; Vol. 24 (1), pp. 702. Date of Electronic Publication: 2024 Jun 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.

• Authors : Cutter DJ; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, United Kingdom.

Subjects: Chemoradiotherapy*/Chemoradiotherapy*/Chemoradiotherapy*/adverse effects ; Chemoradiotherapy*/Chemoradiotherapy*/Chemoradiotherapy*/mortality ; Positron-Emission Tomography*

• Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Nov 10; Vol. 39 (32), pp. 3591-3601. Date of Electronic Publication: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium:

Record details

Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study.

• Authors : Hatton MQF; Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK.; Lawless CA

Subjects: Dose Fractionation, Radiation*; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*therapy ; Chemoradiotherapy/Chemoradiotherapy/Chemoradiotherapy/*methods

• Source: BMJ open [BMJ Open] 2019 Jan 29; Vol. 9 (1), pp. e019903. Date of Electronic Publication: 2019 Jan 29.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy.

• Authors : Douglas KW; Clinical Apheresis Unit, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.; Gilleece M

Subjects: Consensus*; Chemoradiotherapy/Chemoradiotherapy/Chemoradiotherapy/*methods ; Hematopoietic Stem Cell Mobilization/Hematopoietic Stem Cell Mobilization/Hematopoietic Stem Cell Mobilization/*methods

• Source: Journal of clinical apheresis [J Clin Apher] 2018 Feb; Vol. 33 (1), pp. 46-59. Date of Electronic Publication: 2017 Jun 20.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8216305 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial.

• Authors : Jones DA; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Mistry P

Subjects: Cetuximab/Cetuximab/Cetuximab/*therapeutic use ; Chemoradiotherapy/Chemoradiotherapy/Chemoradiotherapy/*methods ; Cisplatin/Cisplatin/Cisplatin/*therapeutic use

• Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Jan; Vol. 124, pp. 178-185. Date of Electronic Publication: 2019 Nov 30.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

[Restaging PET-CT after radiochemotherapy can spare patients with advanced head and neck cancer from neck dissection provided they are in complete remission].

• Authors : Hermann RM; Zentrum für Strahlentherapie, Westerstede, Deutschland.; Christiansen H

Subjects: Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*pathology ; Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/Carcinoma, Squamous Cell/*therapy ; Chemoradiotherapy/Chemoradiotherapy/Chemoradiotherapy/*statistics & numerical data

• Source: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2016 Aug; Vol. 192 (8), pp. 589-91.Publisher: Urban & Vogel Country of Publication: Germany NLM ID: 8603469 Publication Model: Print Cited Medium: Internet ISSN: 1439-099X

Record details

New Cancer Research Has Been Reported by Researchers at Cardiff University (The experiences of patients with oesophageal cancer receiving chemoradiotherapy treatment: a qualitative study embedded in the SCOPE2 trial).

• Source: Medical Letter on the CDC & FDA. 2024, pages. 764

Record details

Clinical significance of pulmonary nodules in decision-making and management of patients diagnosed with esophageal cancer.

• Authors : Dellaportas D; Laliotis A ...

Subjects: Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/epidemiology ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/pathology ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/surgery

• Source: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus [Dis Esophagus] 2020 Mar 16; Vol. 33 (3).Publisher: Oxford University Press Country of Publication: United States NLM ID: 8809160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma.

• Authors : Shakir R; Oxford Cancer and Haematology Centre, Oxford University Hospitals, Oxford, United Kingdom; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Subjects: Neoplasm Recurrence, Local*/Neoplasm Recurrence, Local*/Neoplasm Recurrence, Local*/mortality ; Re-Irradiation*; Anus Neoplasms/Anus Neoplasms/Anus Neoplasms/*therapy

• Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 329-339. Date of Electronic Publication: 2019 Oct 17.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer.

• Authors : Hurt CN; Wales Cancer Trials Unit, College of Biomedical and Life Sciences, Cardiff University, Cardiff, Wales, United Kingdom. Electronic address: .; Mukherjee S

Subjects: Health Status* ; Quality of Life*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

• Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2015 Nov 15; Vol. 93 (4), pp. 810-8. Date of Electronic Publication: 2015 Aug 24.Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details